Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Immuno-Oncology market report explains the definition, types, applications, major countries, and major players of the Immuno-Oncology market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Sanofi SA
Hoffmann-La Roche AG
ImmunoCellular Therapeutics
Eli Lilly and Company
Bristol-Myers Squibb
Incyte
Galena Biopharma
Merck & Co
AstraZeneca, Plc
Prometheus Therapeutics & Diagnostics
Novartis International AG
Celldex Therapeutics
AbbVie
Amgen Inc
Celgene Corporation
Johnson & Johnson
Pfizer Inc
EMD Serono
Aduro BioTech
Bavarian Nordic
Gilead Sciences Inc
By Type:
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
By End-User:
Hospitals
Pharmacies
Online Pharmacies
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Immuno-Oncology Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Immuno-Oncology Outlook to 2028- Original Forecasts
-
2.2 Immuno-Oncology Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Immuno-Oncology Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Immuno-Oncology Market- Recent Developments
-
6.1 Immuno-Oncology Market News and Developments
-
6.2 Immuno-Oncology Market Deals Landscape
7 Immuno-Oncology Raw Materials and Cost Structure Analysis
-
7.1 Immuno-Oncology Key Raw Materials
-
7.2 Immuno-Oncology Price Trend of Key Raw Materials
-
7.3 Immuno-Oncology Key Suppliers of Raw Materials
-
7.4 Immuno-Oncology Market Concentration Rate of Raw Materials
-
7.5 Immuno-Oncology Cost Structure Analysis
-
7.5.1 Immuno-Oncology Raw Materials Analysis
-
7.5.2 Immuno-Oncology Labor Cost Analysis
-
7.5.3 Immuno-Oncology Manufacturing Expenses Analysis
8 Global Immuno-Oncology Import and Export Analysis (Top 10 Countries)
-
8.1 Global Immuno-Oncology Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Immuno-Oncology Export by Region (Top 10 Countries) (2017-2028)
9 Global Immuno-Oncology Market Outlook by Types and Applications to 2022
-
9.1 Global Immuno-Oncology Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Cytokine-Based Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.5 Global CAR-T Cell Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Immuno-Oncology Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Immuno-Oncology Market Analysis and Outlook till 2022
-
10.1 Global Immuno-Oncology Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Immuno-Oncology Consumption (2017-2022)
-
10.2.2 Canada Immuno-Oncology Consumption (2017-2022)
-
10.2.3 Mexico Immuno-Oncology Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Immuno-Oncology Consumption (2017-2022)
-
10.3.2 UK Immuno-Oncology Consumption (2017-2022)
-
10.3.3 Spain Immuno-Oncology Consumption (2017-2022)
-
10.3.4 Belgium Immuno-Oncology Consumption (2017-2022)
-
10.3.5 France Immuno-Oncology Consumption (2017-2022)
-
10.3.6 Italy Immuno-Oncology Consumption (2017-2022)
-
10.3.7 Denmark Immuno-Oncology Consumption (2017-2022)
-
10.3.8 Finland Immuno-Oncology Consumption (2017-2022)
-
10.3.9 Norway Immuno-Oncology Consumption (2017-2022)
-
10.3.10 Sweden Immuno-Oncology Consumption (2017-2022)
-
10.3.11 Poland Immuno-Oncology Consumption (2017-2022)
-
10.3.12 Russia Immuno-Oncology Consumption (2017-2022)
-
10.3.13 Turkey Immuno-Oncology Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Immuno-Oncology Consumption (2017-2022)
-
10.4.2 Japan Immuno-Oncology Consumption (2017-2022)
-
10.4.3 India Immuno-Oncology Consumption (2017-2022)
-
10.4.4 South Korea Immuno-Oncology Consumption (2017-2022)
-
10.4.5 Pakistan Immuno-Oncology Consumption (2017-2022)
-
10.4.6 Bangladesh Immuno-Oncology Consumption (2017-2022)
-
10.4.7 Indonesia Immuno-Oncology Consumption (2017-2022)
-
10.4.8 Thailand Immuno-Oncology Consumption (2017-2022)
-
10.4.9 Singapore Immuno-Oncology Consumption (2017-2022)
-
10.4.10 Malaysia Immuno-Oncology Consumption (2017-2022)
-
10.4.11 Philippines Immuno-Oncology Consumption (2017-2022)
-
10.4.12 Vietnam Immuno-Oncology Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Immuno-Oncology Consumption (2017-2022)
-
10.5.2 Colombia Immuno-Oncology Consumption (2017-2022)
-
10.5.3 Chile Immuno-Oncology Consumption (2017-2022)
-
10.5.4 Argentina Immuno-Oncology Consumption (2017-2022)
-
10.5.5 Venezuela Immuno-Oncology Consumption (2017-2022)
-
10.5.6 Peru Immuno-Oncology Consumption (2017-2022)
-
10.5.7 Puerto Rico Immuno-Oncology Consumption (2017-2022)
-
10.5.8 Ecuador Immuno-Oncology Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Immuno-Oncology Consumption (2017-2022)
-
10.6.2 Kuwait Immuno-Oncology Consumption (2017-2022)
-
10.6.3 Oman Immuno-Oncology Consumption (2017-2022)
-
10.6.4 Qatar Immuno-Oncology Consumption (2017-2022)
-
10.6.5 Saudi Arabia Immuno-Oncology Consumption (2017-2022)
-
10.6.6 United Arab Emirates Immuno-Oncology Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Immuno-Oncology Consumption (2017-2022)
-
10.7.2 South Africa Immuno-Oncology Consumption (2017-2022)
-
10.7.3 Egypt Immuno-Oncology Consumption (2017-2022)
-
10.7.4 Algeria Immuno-Oncology Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Immuno-Oncology Consumption (2017-2022)
-
10.8.2 New Zealand Immuno-Oncology Consumption (2017-2022)
11 Global Immuno-Oncology Competitive Analysis
-
11.1 Sanofi SA
-
11.1.1 Sanofi SA Company Details
-
11.1.2 Sanofi SA Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Sanofi SA Immuno-Oncology Main Business and Markets Served
-
11.1.4 Sanofi SA Immuno-Oncology Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Hoffmann-La Roche AG
-
11.2.1 Hoffmann-La Roche AG Company Details
-
11.2.2 Hoffmann-La Roche AG Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Hoffmann-La Roche AG Immuno-Oncology Main Business and Markets Served
-
11.2.4 Hoffmann-La Roche AG Immuno-Oncology Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 ImmunoCellular Therapeutics
-
11.3.1 ImmunoCellular Therapeutics Company Details
-
11.3.2 ImmunoCellular Therapeutics Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 ImmunoCellular Therapeutics Immuno-Oncology Main Business and Markets Served
-
11.3.4 ImmunoCellular Therapeutics Immuno-Oncology Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Eli Lilly and Company
-
11.4.1 Eli Lilly and Company Company Details
-
11.4.2 Eli Lilly and Company Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Eli Lilly and Company Immuno-Oncology Main Business and Markets Served
-
11.4.4 Eli Lilly and Company Immuno-Oncology Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Bristol-Myers Squibb
-
11.5.1 Bristol-Myers Squibb Company Details
-
11.5.2 Bristol-Myers Squibb Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Bristol-Myers Squibb Immuno-Oncology Main Business and Markets Served
-
11.5.4 Bristol-Myers Squibb Immuno-Oncology Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Incyte
-
11.6.1 Incyte Company Details
-
11.6.2 Incyte Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Incyte Immuno-Oncology Main Business and Markets Served
-
11.6.4 Incyte Immuno-Oncology Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Galena Biopharma
-
11.7.1 Galena Biopharma Company Details
-
11.7.2 Galena Biopharma Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Galena Biopharma Immuno-Oncology Main Business and Markets Served
-
11.7.4 Galena Biopharma Immuno-Oncology Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Merck & Co
-
11.8.1 Merck & Co Company Details
-
11.8.2 Merck & Co Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Merck & Co Immuno-Oncology Main Business and Markets Served
-
11.8.4 Merck & Co Immuno-Oncology Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 AstraZeneca, Plc
-
11.9.1 AstraZeneca, Plc Company Details
-
11.9.2 AstraZeneca, Plc Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 AstraZeneca, Plc Immuno-Oncology Main Business and Markets Served
-
11.9.4 AstraZeneca, Plc Immuno-Oncology Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Prometheus Therapeutics & Diagnostics
-
11.10.1 Prometheus Therapeutics & Diagnostics Company Details
-
11.10.2 Prometheus Therapeutics & Diagnostics Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Prometheus Therapeutics & Diagnostics Immuno-Oncology Main Business and Markets Served
-
11.10.4 Prometheus Therapeutics & Diagnostics Immuno-Oncology Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novartis International AG
-
11.11.1 Novartis International AG Company Details
-
11.11.2 Novartis International AG Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novartis International AG Immuno-Oncology Main Business and Markets Served
-
11.11.4 Novartis International AG Immuno-Oncology Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Celldex Therapeutics
-
11.12.1 Celldex Therapeutics Company Details
-
11.12.2 Celldex Therapeutics Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Celldex Therapeutics Immuno-Oncology Main Business and Markets Served
-
11.12.4 Celldex Therapeutics Immuno-Oncology Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 AbbVie
-
11.13.1 AbbVie Company Details
-
11.13.2 AbbVie Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 AbbVie Immuno-Oncology Main Business and Markets Served
-
11.13.4 AbbVie Immuno-Oncology Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Amgen Inc
-
11.14.1 Amgen Inc Company Details
-
11.14.2 Amgen Inc Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Amgen Inc Immuno-Oncology Main Business and Markets Served
-
11.14.4 Amgen Inc Immuno-Oncology Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Celgene Corporation
-
11.15.1 Celgene Corporation Company Details
-
11.15.2 Celgene Corporation Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Celgene Corporation Immuno-Oncology Main Business and Markets Served
-
11.15.4 Celgene Corporation Immuno-Oncology Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Johnson & Johnson
-
11.16.1 Johnson & Johnson Company Details
-
11.16.2 Johnson & Johnson Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Johnson & Johnson Immuno-Oncology Main Business and Markets Served
-
11.16.4 Johnson & Johnson Immuno-Oncology Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Pfizer Inc
-
11.17.1 Pfizer Inc Company Details
-
11.17.2 Pfizer Inc Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Pfizer Inc Immuno-Oncology Main Business and Markets Served
-
11.17.4 Pfizer Inc Immuno-Oncology Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 EMD Serono
-
11.18.1 EMD Serono Company Details
-
11.18.2 EMD Serono Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 EMD Serono Immuno-Oncology Main Business and Markets Served
-
11.18.4 EMD Serono Immuno-Oncology Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Aduro BioTech
-
11.19.1 Aduro BioTech Company Details
-
11.19.2 Aduro BioTech Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Aduro BioTech Immuno-Oncology Main Business and Markets Served
-
11.19.4 Aduro BioTech Immuno-Oncology Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Bavarian Nordic
-
11.20.1 Bavarian Nordic Company Details
-
11.20.2 Bavarian Nordic Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Bavarian Nordic Immuno-Oncology Main Business and Markets Served
-
11.20.4 Bavarian Nordic Immuno-Oncology Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Gilead Sciences Inc
-
11.21.1 Gilead Sciences Inc Company Details
-
11.21.2 Gilead Sciences Inc Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Gilead Sciences Inc Immuno-Oncology Main Business and Markets Served
-
11.21.4 Gilead Sciences Inc Immuno-Oncology Product Portfolio
-
11.21.5 Recent Research and Development Strategies
12 Global Immuno-Oncology Market Outlook by Types and Applications to 2028
-
12.1 Global Immuno-Oncology Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Cytokine-Based Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global CAR-T Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Immuno-Oncology Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Immuno-Oncology Market Analysis and Outlook to 2028
-
13.1 Global Immuno-Oncology Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Immuno-Oncology Consumption Forecast (2022-2028)
-
13.2.2 Canada Immuno-Oncology Consumption Forecast (2022-2028)
-
13.2.3 Mexico Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.2 UK Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.3 Spain Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.4 Belgium Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.5 France Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.6 Italy Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.7 Denmark Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.8 Finland Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.9 Norway Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.10 Sweden Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.11 Poland Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.12 Russia Immuno-Oncology Consumption Forecast (2022-2028)
-
13.3.13 Turkey Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.2 Japan Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.3 India Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.4 South Korea Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.8 Thailand Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.9 Singapore Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.11 Philippines Immuno-Oncology Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Immuno-Oncology Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Immuno-Oncology Consumption Forecast (2022-2028)
-
13.5.2 Colombia Immuno-Oncology Consumption Forecast (2022-2028)
-
13.5.3 Chile Immuno-Oncology Consumption Forecast (2022-2028)
-
13.5.4 Argentina Immuno-Oncology Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Immuno-Oncology Consumption Forecast (2022-2028)
-
13.5.6 Peru Immuno-Oncology Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Immuno-Oncology Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Immuno-Oncology Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Immuno-Oncology Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Immuno-Oncology Consumption Forecast (2022-2028)
-
13.6.3 Oman Immuno-Oncology Consumption Forecast (2022-2028)
-
13.6.4 Qatar Immuno-Oncology Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Immuno-Oncology Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Immuno-Oncology Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Immuno-Oncology Consumption Forecast (2022-2028)
-
13.7.2 South Africa Immuno-Oncology Consumption Forecast (2022-2028)
-
13.7.3 Egypt Immuno-Oncology Consumption Forecast (2022-2028)
-
13.7.4 Algeria Immuno-Oncology Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Immuno-Oncology Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Immuno-Oncology Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Immuno-Oncology
-
Figure of Immuno-Oncology Picture
-
Table Global Immuno-Oncology Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Immuno-Oncology Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Cytokine-Based Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global CAR-T Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Immuno-Oncology Consumption by Country (2017-2022)
-
Table North America Immuno-Oncology Consumption by Country (2017-2022)
-
Figure United States Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Canada Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Mexico Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Table Europe Immuno-Oncology Consumption by Country (2017-2022)
-
Figure Germany Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure UK Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Spain Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Belgium Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure France Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Italy Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Denmark Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Finland Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Norway Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Sweden Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Poland Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Russia Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Turkey Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Table APAC Immuno-Oncology Consumption by Country (2017-2022)
-
Figure China Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Japan Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure India Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Thailand Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Singapore Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Philippines Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Table South America Immuno-Oncology Consumption by Country (2017-2022)
-
Figure Brazil Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Colombia Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Chile Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Argentina Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Peru Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Table GCC Immuno-Oncology Consumption by Country (2017-2022)
-
Figure Bahrain Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Oman Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Qatar Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Table Africa Immuno-Oncology Consumption by Country (2017-2022)
-
Figure Nigeria Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure South Africa Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Egypt Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure Algeria Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Table Oceania Immuno-Oncology Consumption by Country (2017-2022)
-
Figure Australia Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Immuno-Oncology Consumption and Growth Rate (2017-2022)
-
Table Sanofi SA Company Details
-
Table Sanofi SA Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Immuno-Oncology Main Business and Markets Served
-
Table Sanofi SA Immuno-Oncology Product Portfolio
-
Table Hoffmann-La Roche AG Company Details
-
Table Hoffmann-La Roche AG Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann-La Roche AG Immuno-Oncology Main Business and Markets Served
-
Table Hoffmann-La Roche AG Immuno-Oncology Product Portfolio
-
Table ImmunoCellular Therapeutics Company Details
-
Table ImmunoCellular Therapeutics Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmunoCellular Therapeutics Immuno-Oncology Main Business and Markets Served
-
Table ImmunoCellular Therapeutics Immuno-Oncology Product Portfolio
-
Table Eli Lilly and Company Company Details
-
Table Eli Lilly and Company Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Immuno-Oncology Main Business and Markets Served
-
Table Eli Lilly and Company Immuno-Oncology Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Immuno-Oncology Main Business and Markets Served
-
Table Bristol-Myers Squibb Immuno-Oncology Product Portfolio
-
Table Incyte Company Details
-
Table Incyte Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Immuno-Oncology Main Business and Markets Served
-
Table Incyte Immuno-Oncology Product Portfolio
-
Table Galena Biopharma Company Details
-
Table Galena Biopharma Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galena Biopharma Immuno-Oncology Main Business and Markets Served
-
Table Galena Biopharma Immuno-Oncology Product Portfolio
-
Table Merck & Co Company Details
-
Table Merck & Co Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Immuno-Oncology Main Business and Markets Served
-
Table Merck & Co Immuno-Oncology Product Portfolio
-
Table AstraZeneca, Plc Company Details
-
Table AstraZeneca, Plc Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca, Plc Immuno-Oncology Main Business and Markets Served
-
Table AstraZeneca, Plc Immuno-Oncology Product Portfolio
-
Table Prometheus Therapeutics & Diagnostics Company Details
-
Table Prometheus Therapeutics & Diagnostics Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prometheus Therapeutics & Diagnostics Immuno-Oncology Main Business and Markets Served
-
Table Prometheus Therapeutics & Diagnostics Immuno-Oncology Product Portfolio
-
Table Novartis International AG Company Details
-
Table Novartis International AG Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International AG Immuno-Oncology Main Business and Markets Served
-
Table Novartis International AG Immuno-Oncology Product Portfolio
-
Table Celldex Therapeutics Company Details
-
Table Celldex Therapeutics Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celldex Therapeutics Immuno-Oncology Main Business and Markets Served
-
Table Celldex Therapeutics Immuno-Oncology Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Immuno-Oncology Main Business and Markets Served
-
Table AbbVie Immuno-Oncology Product Portfolio
-
Table Amgen Inc Company Details
-
Table Amgen Inc Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Immuno-Oncology Main Business and Markets Served
-
Table Amgen Inc Immuno-Oncology Product Portfolio
-
Table Celgene Corporation Company Details
-
Table Celgene Corporation Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Immuno-Oncology Main Business and Markets Served
-
Table Celgene Corporation Immuno-Oncology Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Immuno-Oncology Main Business and Markets Served
-
Table Johnson & Johnson Immuno-Oncology Product Portfolio
-
Table Pfizer Inc Company Details
-
Table Pfizer Inc Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Immuno-Oncology Main Business and Markets Served
-
Table Pfizer Inc Immuno-Oncology Product Portfolio
-
Table EMD Serono Company Details
-
Table EMD Serono Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table EMD Serono Immuno-Oncology Main Business and Markets Served
-
Table EMD Serono Immuno-Oncology Product Portfolio
-
Table Aduro BioTech Company Details
-
Table Aduro BioTech Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aduro BioTech Immuno-Oncology Main Business and Markets Served
-
Table Aduro BioTech Immuno-Oncology Product Portfolio
-
Table Bavarian Nordic Company Details
-
Table Bavarian Nordic Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bavarian Nordic Immuno-Oncology Main Business and Markets Served
-
Table Bavarian Nordic Immuno-Oncology Product Portfolio
-
Table Gilead Sciences Inc Company Details
-
Table Gilead Sciences Inc Immuno-Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Inc Immuno-Oncology Main Business and Markets Served
-
Table Gilead Sciences Inc Immuno-Oncology Product Portfolio
-
Figure Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cytokine-Based Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CAR-T Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immuno-Oncology Consumption Forecast by Country (2022-2028)
-
Table North America Immuno-Oncology Consumption Forecast by Country (2022-2028)
-
Figure United States Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immuno-Oncology Consumption Forecast by Country (2022-2028)
-
Figure Germany Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Immuno-Oncology Consumption Forecast by Country (2022-2028)
-
Figure China Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Immuno-Oncology Consumption Forecast by Country (2022-2028)
-
Figure Brazil Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Immuno-Oncology Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Immuno-Oncology Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Immuno-Oncology Consumption Forecast by Country (2022-2028)
-
Figure Australia Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Immuno-Oncology Consumption Forecast and Growth Rate (2022-2028)
-
